Catherine B Johannes

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 16

Top Topics

Urinary Tract Infection

Extracorporeal Membrane Oxygenation

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Djeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, Catherine W Saltus, Patricia Shuminski, James A Kaye, Catherine B Johannes, Mark Libertin, Shelli Graham
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims. Pharmacoepidemiology and drug safety (2023)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Catherine W Saltus, James A Kaye, Brian Calingaert, Sigal Kaplan, Mark Forrest Gordon, Elizabeth B Andrews
The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database. Pharmacoepidemiology and drug safety 31 (6) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Heather E Danysh, Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety 46 (2) (2022)
Catherine B Johannes, Daniel C Beachler, J Bradley Layton, Heather E Danysh, Ryan Ziemiecki, Alejandro Arana, Jade Dinh, Ling Li, Brian Calingaert, Manel Pladevall, Phillip R Hunt, Hungta Chen, Cecilia Karlsson, Kristina Johnsson, Alicia W Gilsenan
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety (2022)